Justin Zamirowski Appointed as Chief Commercial Officer
Justin Zamirowski to lead upcoming launches of Better Therapeutics’ maturing prescription digital therapeutics product portfolio with a near term focus on type 2 diabetes and associated comorbidities.
We recently announced the appointment of Justin Zamirowski as Chief Commercial Officer. In this role, Justin will be responsible for market development and commercial operations. He will immediately begin developing the go-to-market plans for the company’s first prescription digital therapeutic for the treatment of type 2 diabetes, and follow on indications addressing related comorbidities.
“We are thrilled to welcome Justin to the Better team,” said Kevin Appelbaum, CEO. “His deep commercial leadership expertise and breadth of experience launching regulated products across multiple systems of care, treatment settings, and therapeutic areas will be key to developing a commercial capability as innovative as our products.”
Justin joins Better from Guidehouse (formerly Navigant Consulting), where he led the commercial launch practice for pharmaceutical, medical device, and biotech companies. Prior to Guidehouse, he held commercial leadership roles at Edge Therapeutics and Otsuka Pharmaceutical, among others.